| Date Filed | Type | Description |
| 10/22/2010 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 10/19/2010 |
EFFECT
| Form EFFECT - |
| 10/19/2010 |
EFFECT
| Form EFFECT - |
| 10/14/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 10/14/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 10/14/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/14/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/12/2010 |
8-K
| Quarterly results |
| 10/12/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/12/2010 |
SC 13G/A
| ZYMOGENETICS INC reports a 0% stake in ZYMOGENETICS, INC. |
| 10/08/2010 |
SC 13D/A
| ZYMOGENETICS INC has filed a Schedule 13D for ZYMOGENETICS, INC. |
| 10/05/2010 |
SC 13D/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/29/2010 |
SC 13D/A
| ZYMOGENETICS INC has filed a Schedule 13D for ZYMOGENETICS, INC. |
| 09/29/2010 |
SC 13D/A
| ZYMOGENETICS INC has filed a Schedule 13D for ZYMOGENETICS, INC. |
| 09/29/2010 |
BW
| ZymoGenetics Reports Favorable Survival Data from IL-21 Phase 2a Clinical Trial in Melanoma |
| 09/28/2010 |
SC 13D/A
| ZYMOGENETICS INC has filed a Schedule 13D for ZYMOGENETICS, INC. |
| 09/17/2010 |
SC 13D/A
| ZYMOGENETICS INC has filed a Schedule 13D for ZYMOGENETICS, INC. |
| 09/15/2010 |
SC 13D
| BRISTOL MYERS SQUIBB CO reports a 36.4% stake in ZymoGenetics, Inc. |
| 09/13/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/10/2010 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 09/08/2010 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...|
Docs:
|
"Agreement and Plan of Merger, by and among ZymoGenetics, Inc., Bristol-Myers Squibb Company and Zeus Acquisition Corporation",
"Form of Tender and Support Agreement",
"ZymoGenetics, Inc. Retention and Severance Plan, adopted on August 27, 2010, as amended on September 3, 2010 and September 7, 2010" |
|
| 09/08/2010 |
SC 13D/A
| WARBURG PINCUS LLC reports a 10.9% stake in ZymoGenetics, Inc. |
| 09/08/2010 |
BW
| Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of ZymoGenetics, Inc. – ZGEN |
| 09/08/2010 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 09/08/2010 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 09/08/2010 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 09/08/2010 |
BW
| The Law Offices of Vincent Wong Announces an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ZymoGenetics, Inc. - ZGEN |
| 09/08/2010 |
BW
| The Briscoe Law Firm Investigates ZymoGenetics Inc.'s Board Concerning the Acquisition of ZymoGenetics by Bristol-Myers Squibb Company |
| 09/08/2010 |
BW
| Ryan & Maniskas, LLP Announces Investigation of ZymoGenetics, Inc. |
| 09/07/2010 |
BW
| The Law Office of Robbins Umeda LLP Announces an Investigation of the Tender Offer by Bristol-Myers Squibb Company to Acquire ZymoGenetics, Inc. |
| 09/07/2010 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 09/07/2010 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 09/07/2010 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
|